Adia Med Inc ADIA
OTC PK
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Revenue | 175.33% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 175.33% | ||||
| Cost of Revenue | 85.96% | ||||
| Gross Profit | 322.52% | ||||
| SG&A Expenses | 4.05% | ||||
| Depreciation & Amortization | 7.69% | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 32.11% | ||||
| Operating Income | 134.10% | ||||
| Income Before Tax | 124.86% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | 124.86% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 124.86% | ||||
| EBIT | 134.10% | ||||
| EBITDA | 140.86% | ||||
| EPS Basic | 123.53% | ||||
| Normalized Basic EPS | 127.27% | ||||
| EPS Diluted | 117.65% | ||||
| Normalized Diluted EPS | 118.18% | ||||
| Average Basic Shares Outstanding | 0.00% | ||||
| Average Diluted Shares Outstanding | 70.97% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||